Home » Reports » Broker Ratings » AstraZeneca plc 22.5% Potential Decrease Indicated by Goldman Sachs

AstraZeneca plc 22.5% Potential Decrease Indicated by Goldman Sachs

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘SELL’ today by analysts at Goldman Sachs. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Goldman Sachs have set their target price at 5500 GBX on its stock. This now indicates the analyst believes there is a potential downside of -22.5% from today’s opening price of 7100 GBX. Over the last 30 and 90 trading days the company share price has increased 663 points and increased 1347 points respectively. The 1 year high for the share price is 7270 GBX while the 52 week low for the share price is 5312 GBX.

AstraZeneca plc has a 50 day moving average of 6,470.89 GBX and the 200 Day Moving Average price is recorded at 6,153.31. There are currently 1,311,876,336 shares in issue with the average daily volume traded being 2,090,123. Market capitalisation for LON:AZN is £93,365,450,938 GBP.